newsfilter
← Latest News
PR Newswire·

Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs

  • Elanco Animal Health received USDA approval for TruCan Ultra Lyme-L4, the first and only 1/2 mL combination vaccine for dogs protecting against Lyme disease & leptospirosis
  • The low-volume formulation combines two protections into a single injection to minimize "pokes" & support comfortable wellness visits
  • The product utilizes proprietary PureFil™ Technology designed to reduce vaccination reactions associated with unwanted proteins
  • Leptospirosis is now recognized as a core vaccine per AAHA guidelines due to nationwide exposure risks regardless of breed or location
  • Over 40% of at-risk dogs in endemic states lack current Lyme vaccination despite having received core vaccines
  • TruCan Ultra Lyme vaccines demonstrated 92.2% efficacy against natural infection in endemic areas & 100% efficacy in laboratory studies
  • Shipping is expected to begin within the next 30 days
  • This approval follows recent USDA endorsements for TruCan Ultra B (Oral) & TruCan Ultra CIV H3N2/H3N8 as part of the expanding TruCan Ultra Portfolio